Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Embodied Conversational Agent (ECA) as an Oncology Trial Advisor

NCT02742740 is registered in ClinicalTrials.gov with Boston Medical Center as lead sponsor.

NCT NCT02742740
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02742740 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Embodied Conversational Agent (ECA) as an Oncology Trial Advisor
Lead sponsor
Boston Medical Center
Phase
Not applicable
Overall status
Completed
Start date
September 1, 2017
Completion date
April 30, 2018
Enrollment
4 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

guideline adherence, patient compliance, patient satisfaction